Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer

HIGHLIGHTS

• who: Philipp Wolf from the British Columbia Cancer Agency, Canada Department of Urology, Medical Center-University of Freiburg, Freiburg, Germany, Faculty of have published the Article: Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer, in the Journal: (JOURNAL)
• future: Future studies will demonstrate whether this inhibitor is also effective in BC. A key point in future is to establish appropriate investigational models to assess the efficacy of IAP targeting in BC patients.Targeting of IAPs has been previously studied in Frontiers in Oncology frontiersin.org 10.3389/fonc.2023.1124600 Therefore their expression . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.